Navigation Links
University of Houston develops method for creating single-crystal arrays of graphene
Date:6/2/2011

University of Houston researchers have developed a method for creating single-crystal arrays of the material graphene, an advance that opens the possibility of a replacement for silicon in high-performance computers and electronics. The work by UH researchers and their collaborators is featured on the cover of the June issue of Nature Materials.

Graphene is a one-atom-thick layer of carbon that was first fabricated in 2004. Single-crystal arrays of the material could be used to create a new class of high-speed transistors and integrated circuits that use less energy than silicon electronics because graphene conducts electricity with little resistance or heat generation.

But the industry needs a reliable and defect-free method for manufacturing large quantities of single crystals of graphene. The development reported in Nature Materials marks a step towards perfecting such a method.

"Using these seeds, we can grow an ordered array of thousands or millions of single crystals of graphene," said Qingkai Yu, the paper's first author. Yu developed the single-crystal growth process at the UH Center for Advanced Materials (CAM), where he was a research assistant professor of electrical and computer engineering.

"We hope the industry will look at these findings and consider the ordered arrays as a possible means of fabricating electronic devices," said Yu, who is now an assistant professor at Texas State University in San Marcos and remains a project leader at CAM.

Yu and Steven Pei, UH professor of electrical and computer engineering and CAM's deputy director, invented the graphene seeded-growth technique that UH patented in 2010.

"There is still a long way to go. However, this development makes the fabrication of integrated circuits with graphene transistors possible. This may actually be the first viable integrated circuit technology based on nano-electronics," Pei said.

Yong P. Chen, an assistant professor of nanoscience and physics at Purdue University, was the paper's co-corresponding author.

At CAM, single-crystal graphene arrays were grown on top of a copper foil inside a chamber containing methane gas using a process called chemical vapor deposition. This process was pioneered by Yu at CAM in 2008 and is now widely accepted as the standard method to create large-area graphene films for potential applications in touch-screen displays, e-books and solar cells.

"Graphene isn't there yet, in terms of high quality mass production like silicon, but this is a very important step in that direction," said Chen, who led the graphene characterization efforts at Purdue.

In addition to Yu and Pei, UH graduate students Wei Wu and Zhihua Su, postdoctoral researchers Zhihong Liu and Peng Peng and assistant professor Jiming Bao along with Chen and nine other researchers from Purdue University, Brookhaven National Laboratory, Argonne National Laboratories and Carl Zeiss SMT Inc. co-authored the paper.

Last year, two scientists received the Nobel Prize in physics for discovering graphene. At that time, Yu was working at CAM to develop ways to produce mass quantities of high-quality graphene.

The findings reported in Nature Materials demonstrated that researchers could control the growth of the ordered arrays. The researchers also were the first to demonstrate the electronic properties of individual grain boundaries.


'/>"/>

Contact: Laura Tolley
ljtolley@uh.edu
713-743-0778
University of Houston
Source:Eurekalert

Related biology technology :

1. NIH Funds $1M Research at Quest Product Development and University of Colorado for New Digitally-Controlled Endoscopes
2. University of Pennsylvania scientists move optical computing closer to reality
3. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
4. University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia
5. Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
6. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
7. George Washington University Hospital Purchases Orthocrats TraumaCad(TM) for Orthopedic Preoperative Planning
8. Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement
9. Brain and Hearing Pioneer, Michael Merzenich, Ph.D. to Speak at Case Western Reserve University
10. Stuart Parkin first distinguished professor at Eindhoven University of Technology
11. McMaster University unveils worlds most advanced microscope
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... NextSteps 2017, ... North America this May on the following dates: , ?    London, UK ... Chairman of the Learning and Performance Institute will be the opening keynote ...
(Date:4/25/2017)... ... ... As part of the Stago EdVantage Virtual University Virtual Event, ... order to illuminate this clinical problem for people unfamiliar with the topic. , DIC ... high degree of morbidity and mortality. DIC is a confusing disorder from both diagnostic ...
(Date:4/25/2017)... , April 25, 2017 ... has licensed its novel immune-modulating technology to an undisclosed ... and allergy. Tregitopes, pronounced T·rej·itopes, are ... immunoglobulin by EpiVax CEO Annie De Groot ... intravenous immunoglobulin G, an autoimmune disease therapy, Tregitopes ...
(Date:4/25/2017)... ... 2017 , ... Leaders of Quorum Review IRB and Kinetiq ... at this week’s Association of Clinical Research Professionals (ACRP) 2017 Meeting & Expo ... , "We are excited to present subject matter expertise on topics that impact the ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):